Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Dyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
REGENXBIO Announces Presentation at Chardan's 6th Annual Genetic Medicines Conference
-
Silence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines Conference
-
Voyager Therapeutics to Participate in Upcoming Investor Conferences
-
Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference
-
Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference
-
Intellia Therapeutics to Present at October Healthcare Investor Conferences
-
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
-
Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Oncorus to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Passage Bio to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Century Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Oncorus to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Passage Bio to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Sensorion to Participate in Various Upcoming Investor Conferences
-
Form 4 Presto Automation Inc. For: Sep 21 Filed by: Chardan International Investments, LLC
-
UPDATE: Chardan Capital Markets Starts Omega Therapeutics (OMGA) at Buy
-
UPDATE: Chardan Capital Markets Starts Senti Biosciences, Inc. (SNTI) at Buy, PT $12
-
NeuBase to Participate at Chardan’s 6th Annual Genetic Medicines Conference
-
Arbor Biotechnologies to Participate in Upcoming Healthcare Investor Conferences
-
NextRNA Therapeutics to Participate in Upcoming BioPharm America and Chardan’s 6th Annual Genetic Medicines Conference
-
Arbutus to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Arbutus to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
-
Presto to Become Publicly Traded Following Business Combination with Ventoux CCM Acquisition Corp. (VTAQ)
-
Presto, One of the Largest Labor Automation Technology Providers for the Hospitality Industry, to Become Publicly Traded Following Business Combination with Ventoux CCM Acquisition Corp.
-
4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
-
4D Molecular Therapeutics to Participate in Upcoming Investor Conferences
-
Senti Bio to Participate in Chardan’s 6th Annual Genetic Medicines Conference
-
Senti Bio to Participate in Chardan’s 6th Annual Genetic Medicines Conference
-
Coave Therapeutics to Present at Chardan's 6th Annual Genetic Medicines Conference
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
GenSight Biologics to Present at Upcoming Industry and Investor Conferences
-
Chardan NexTech Acquisition 2 Corp. Announces Effectiveness of Registration Statement and October 6, 2022 Special Meeting of Stockholders to Approve Business Combination with Dragonfly Energy Corp.
-
Form EFFECT Chardan NexTech Acquisit
-
Form 424B3 Chardan NexTech Acquisit
-
Ventoux CCM Acquisition (VTAQ) Stockholders Approve Proposed Business Combination with Presto
-
Ventoux CCM Acquisition Corp. Stockholders Approve Proposed Business Combination with Presto
-
Form S-4/A Chardan NexTech Acquisit
-
Form S-4/A Chardan NexTech Acquisit
-
UPDATE: Chardan Capital Markets Starts Outlook Therapeutics Incs. (OTLK) at Buy; Bullish on ONS-5010 for Wet AMD
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
CleanTech Acquisition Corp. (CLAQ) and Nauticus Robotics, Inc. Complete Business Combination (KITT)
-
CleanTech Acquisition Corp. and Nauticus Robotics, Inc. Complete Business Combination
-
CleanTech Acquisition Corp. and Nauticus Robotics, Inc. Complete Business Combination
-
Form 425 Chardan NexTech Acquisit Filed by: Chardan NexTech Acquisition 2 Corp.
-
MeiraGTx to Participate in Upcoming Investor Conferences
-
MeiraGTx to Participate in Upcoming Investor Conferences
-
Chardan Announces the Inaugural SPICI (Smart People in Cellular Immunotherapy) Symposium
